Terms: = Leukemia AND CEACAM5, CEA AND Treatment
21 results:
1. The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia.
Conti RM; Padula WV; Becker RV; Salamone S
J Manag Care Spec Pharm; 2021 Aug; 27(8):1077-1085. PubMed ID: 34337991
[No Abstract] [Full Text] [Related]
2. Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme.
Kazemi Shariat Panahi H; Dehhaghi M; Lam SS; Peng W; Aghbashlo M; Tabatabaei M; Guillemin GJ
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1122-1142. PubMed ID: 34004331
[TBL] [Abstract] [Full Text] [Related]
3. Accuracy evaluation of the C. elegans cancer test (N-NOSE) using a new combined method.
Inaba S; Shimozono N; Yabuki H; Enomoto M; Morishita M; Hirotsu T; di Luccio E
Cancer Treat Res Commun; 2021; 27():100370. PubMed ID: 33901923
[TBL] [Abstract] [Full Text] [Related]
4. Identification of hub genes associated with adult acute myeloid leukemia progression through weighted gene co-expression network analysis.
Zhu R; Lin W; Tang L; Hu Y
Aging (Albany NY); 2021 Feb; 13(4):5686-5697. PubMed ID: 33592582
[TBL] [Abstract] [Full Text] [Related]
5. Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment.
Zhao Z; Xiao X; Saw PE; Wu W; Huang H; Chen J; Nie Y
Sci China Life Sci; 2020 Feb; 63(2):180-205. PubMed ID: 31883066
[TBL] [Abstract] [Full Text] [Related]
6. Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30
Hombach AA; Rappl G; Abken H
Mol Ther; 2019 Oct; 27(10):1825-1835. PubMed ID: 31331813
[TBL] [Abstract] [Full Text] [Related]
7. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
[No Abstract] [Full Text] [Related]
8. Harnessing T cells to fight cancer with BiTE® antibody constructs--past developments and future directions.
Klinger M; Benjamin J; Kischel R; Stienen S; Zugmaier G
Immunol Rev; 2016 Mar; 270(1):193-208. PubMed ID: 26864113
[TBL] [Abstract] [Full Text] [Related]
9. cea, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
Wang XF; Wu YH; Wang MS; Wang YS
Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
[TBL] [Abstract] [Full Text] [Related]
10. Systematic assessment of decision-analytic models for chronic myeloid leukemia.
Rochau U; Schwarzer R; Jahn B; Sroczynski G; Kluibenschaedl M; Wolf D; Radich J; Brixner D; Gastl G; Siebert U
Appl Health Econ Health Policy; 2014 Apr; 12(2):103-15. PubMed ID: 24385259
[TBL] [Abstract] [Full Text] [Related]
11. Differential cell fates induced by all-trans retinoic acid-treated HL-60 human leukemia cells.
Ozeki M; Shively JE
J Leukoc Biol; 2008 Sep; 84(3):769-79. PubMed ID: 18552205
[TBL] [Abstract] [Full Text] [Related]
12. In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.
Santegoets SJ; Schreurs MW; Masterson AJ; Liu YP; Goletz S; Baumeister H; Kueter EW; Lougheed SM; van den Eertwegh AJ; Scheper RJ; Hooijberg E; de Gruijl TD
Cancer Immunol Immunother; 2006 Dec; 55(12):1480-90. PubMed ID: 16468034
[TBL] [Abstract] [Full Text] [Related]
13. Retinoic acid treated HL60 cells express ceaCAM1 (CD66a) and phagocytose Neisseria gonorrhoeae.
Pantelic M; Chen I; Parker J; Zhang P; Grunert F; Chen T
FEMS Immunol Med Microbiol; 2004 Oct; 42(2):261-6. PubMed ID: 15364113
[TBL] [Abstract] [Full Text] [Related]
14. Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of ceaCAM1 (CD66a).
Håkansson P; Lassen C; Olofsson T; Baldetorp B; Karlsson A; Gullberg U; Fioretos T
Leukemia; 2004 Mar; 18(3):538-47. PubMed ID: 14712293
[TBL] [Abstract] [Full Text] [Related]
15. In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA-50/90), a member of the cea family.
Di Noto R; Boccuni P; Costantini S; Dello Russo A; Lo Pardo C; Copia C; Annunziata M; Cimino R; Ferrara F; Del Vecchio L
Tissue Antigens; 1999 Dec; 54(6):597-602. PubMed ID: 10674975
[TBL] [Abstract] [Full Text] [Related]
16. [Drug-induced hepatitis].
Polunina TE
Ter Arkh; 1999; 71(12):46-9. PubMed ID: 10647202
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of neuroendocrine markers, HER2 and cea before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and leukemia Group B study.
Graziano SL; Kern JA; Herndon JE; Tatum A; Brisson ML; Memoli V; Sugarbaker D; Skarin AT; Kreisman H; Green MR
Lung Cancer; 1998 Sep; 21(3):203-11. PubMed ID: 9857998
[TBL] [Abstract] [Full Text] [Related]
18. [Polycystic endodermal heterotopy of the atrioventricular node].
Monzón Muñoz FJ; Aguilera Tapia B; Martínez-Peñuela Virseda JM; Oliva Aldamiz H
Med Clin (Barc); 1995 Feb; 104(7):257-61. PubMed ID: 7731290
[TBL] [Abstract] [Full Text] [Related]
19. Regulation of the cell surface expression of a nonspecific cross-reacting antigen variant during differentiation of HL-60 cells.
Novak-Hofer I; Bläuenstein P; Schubiger PA
Cancer Res; 1990 Dec; 50(23):7437-43. PubMed ID: 2174725
[TBL] [Abstract] [Full Text] [Related]
20. Carcinoembryonic antigen, alphafetoprotein and alpha and beta subunits of human chorionic gonadotropin in plasma of children with acute leukaemia.
Wysocki M; Domaniewski J; Balcar-Boroń A; Cetnarowski L; Czerwionka-Szaflarska M; Sujkowska R
Acta Paediatr Hung; 1987; 28(2):119-25. PubMed ID: 2447919
[TBL] [Abstract] [Full Text] [Related]
[Next]
